Technology Transfer

- The International Perspective -

Successful translation of discovery into therapy

20191021_181538.jpg

Technology transfer from academia to industry is an important part of health innovation. However, the interplay between research institutions, startups, venture capitalists, and pharmaceutical companies is a complex process.
Together with the Heidelberg Startup Partners we organised an intensive afterwork session on October 21st in Heidelberg. Regional and international key opinion leaders discussed best-practice and new ideas in technology transfer. 

  • Christina Takke, Managing Partner at V-Bio Ventures

  • Joern-Peter Halle, Head of External Innovation & TIP Immuno-Oncology, Merck

  • Phil Elstob, Commercialisation Director at Cambridge Enterprise

  • Andreas Jenne, Former CEO at RSP System

Source: BioRN